Prevalence of low bone mineral density among people living with HIV

References

• Afzelius, P., Garding, M. M., & Molsted, S. (2017, July 9). Dual-energy X-ray absorptiometry of both hips helps appropriate diagnosis of low bone mineral density and osteoporosis. Diagnostics (Basel, Switzerland), 7(3). https://doi.org/https://doi.org/10.3390/diagnostics7030041.
   Google Scholar
• Akkawi, I., & Zmerly, H. (2018, June). Osteoporosis: Current Concepts. Joints, 6(2), 122–15. https://doi.org/https://doi.org/10.1055/s-0038-1660790
   PubMedGoogle Scholar
• Arnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Lo, Y., & Klein, R. S. (2007, March). Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS, 21(5), 617–623. https://doi.org/https://doi.org/10.1097/QAD.0b013e3280148c05
   PubMed Web of Science ®Google Scholar
• Bedimo, R., Maalouf, N. M., Zhang, S., Drechsler, H., & Tebas, P. (2012, April). Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS, 26(7), 825–831. https://doi.org/https://doi.org/10.1097/QAD.0b013e32835192ae
   PubMed Web of Science ®Google Scholar
• Bedimo, R. J., Drechsler, H., Jain, M., Cutrell, J., Zhang, S., Li, X., Farukhi, I., Castanon, R., Tebas, P., & Maalouf, N. M. (2014). The RADAR study: Week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health. PLoS One, 9(8), e106221. https://doi.org/https://doi.org/10.1371/journal.pone.0106221
   PubMed Web of Science ®Google Scholar
• Bonjoch, A., Figueras, M., Estany, C., Perez-Alvarez, N., Rosales, J., Del, R. L., Di Gregorio, S., Puig, J., Gómez, G., Clotet, B., & Negredo, E. (2010, November). High prevalence of and progression to low bone mineral density in HIV-infected patients: A longitudinal cohort study. AIDS, 24(18), 2827–2833. https://doi.org/https://doi.org/10.1097/QAD.0b013e328340a28d
   PubMed Web of Science ®Google Scholar
• Borges, A. H., Hoy, J., Florence, E., Sedlacek, D., Stellbrink, H. J., Uzdaviniene, V., Tomazic, J., Gargalianos-Kakolyris, P., Schmid, P., Orkin, C., Pedersen, C., Leen, C., Pradier, C., Mulcahy, F., Ridolfo, A. L., Staub, T., Maltez, F., Weber, R., Flamholc, L., … Mocroft, A. (2017, May). Antiretrovirals, fractures, and osteonecrosis in a large international HIV cohort. Clinical Infectious Diseases, 64(10), 1413–1421. https://doi.org/https://doi.org/10.1093/cid/cix167
   PubMed Web of Science ®Google Scholar
• Cervero, M., Torres, R., Agud, J. L., Alcazar, V., Jusdado, J. J., Garcia-Lacalle, C., & Moreno, S. (2018). Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients. PLoS One, 13(4), e0196201. https://doi.org/https://doi.org/10.1371/journal.pone.0196201
   PubMed Web of Science ®Google Scholar
• Compston, J. (2016, October). HIV infection and bone disease. Journal of Internal Medicine, 280(4), 350–358. https://doi.org/https://doi.org/10.1111/joim.12520
   PubMed Web of Science ®Google Scholar
• Ehnert, S., Linnemann, C., Aspera-Werz, R. H., Häussling, V., Braun, B., Weng, W., Zhu, S., Ngamsri, K. C., & Nussler, A. (2020). Feasibility of cell lines for in vitro co-cultures models for bone metabolism. SciMedicine Journal, 2(3), 157–181. https://doi.org/https://doi.org/10.28991/SciMedJ-2020-0203-6
   Google Scholar
• Erlandson, K. M., Lake, J. E., Sim, M., Falutz, J., Prado, C. M., Domingues da Silva, A. R., Brown, T. T., & Guaraldi, G. (2018, March 1). Bone mineral density declines twice as quickly among HIV-Infected women compared with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 77(3), 288–294. https://doi.org/https://doi.org/10.1097/QAI.0000000000001591
   PubMed Web of Science ®Google Scholar
• Escota, G. V., Mondy, K., Bush, T., Conley, L., Brooks, J. T., Onen, N., Patel, P., Kojic, E. M., Henry, K., Hammer, J., Wood, K. C., Lichtenstein, K. A., & Overton, E. T. (2016, January). High prevalence of low bone mineral density and substantial bone loss over 4 years among HIV-infected persons in the era of modern antiretroviral therapy. AIDS Research and Human Retroviruses, 32(1), 59–67. https://doi.org/https://doi.org/10.1089/aid.2015.0158
   PubMed Web of Science ®Google Scholar
• Goh, S. S. L., Lai, P. S. M., Tan, A. T. B., & Ponnampalavanar, S. (2018, March). Reduced bone mineral density in human immunodeficiency virus-infected individuals: A meta-analysis of its prevalence and risk factors. Osteoporosis International, 29(3), 595–613. https://doi.org/https://doi.org/10.1007/s00198-017-4305-8
   PubMed Web of Science ®Google Scholar
• Goltzman, D. (2019). The ageing skeleton. Advancesin Experimental Medicine, 1164, 153–160. doi: https://doi.org/10.1007/978-3-030-22254-3_12.
   Google Scholar
• Graat-Verboom, L., Smeenk, F. W., van den Borne, B. E., Spruit, M. A., Jansen, F. H., van Enschot, J. W., & Wouters, E. F. M. (2012, June). Progression of osteoporosis in patients with COPD: A 3-year follow up study. Respiratory Medicine, 106(6), 861–870. https://doi.org/https://doi.org/10.1016/j.rmed.2011.12.020
   PubMed Web of Science ®Google Scholar
• Grant, P. M., Kitch, D., McComsey, G. A., Dube, M. P., Haubrich, R., Huang, J., Riddler, S., Tebas, P., Zolopa, A. R., Collier, A. C., & Brown, T. T. (2013, November). Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clinical Infectious Diseases, 57(10), 1483–1488. https://doi.org/https://doi.org/10.1093/cid/cit538
   PubMed Web of Science ®Google Scholar
• Hansen, A. B., Gerstoft, J., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., & Obel, N. (2012, January). Incidence of low and high-energy fractures in persons with and without HIV infection: A Danish population-based cohort study. AIDS, 26(3), 285–293. https://doi.org/https://doi.org/10.1097/QAD.0b013e32834ed8a7
   PubMed Web of Science ®Google Scholar
• Hansen, A. B., Obel, N., Nielsen, H., Pedersen, C., & Gerstoft, J. (2011, March). Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: Data from a randomized trial. HIV Medicine, 12(3), 157–165. https://doi.org/https://doi.org/10.1111/j.1468-1293.2010.00864.x
   PubMed Web of Science ®Google Scholar
• Haskelberg, H., Hoy, J. F., Amin, J., Ebeling, P. R., Emery, S., Carr, A., et al. (2012). Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One, 7(6), e38377. https://doi.org/https://doi.org/10.1371/journal.pone.0038377
   PubMed Web of Science ®Google Scholar
• Hirakawa, H., Gatanaga, H., Ochi, H., Fukuda, T., Sunamura, S., Oka, S., Takeda, S., & Sato, S. (2017, June). Antiretroviral therapy containing HIV protease inhibitors enhances fracture risk by impairing osteoblast differentiation and bone quality. The Journal of Infectious Diseases, 215(12), 1893–1897. https://doi.org/https://doi.org/10.1093/infdis/jix246
   PubMed Web of Science ®Google Scholar
• Hood, J. E., Golden, M. R., Hughes, J. P., Goodreau, S. M., Siddiqi, A. E., Buskin, S. E., & Hawes, S. E. (2017, December). Projected demographic composition of the United States population of people living with diagnosed HIV. AIDS Care, 29(12), 1543–1550. https://doi.org/https://doi.org/10.1080/09540121.2017.1308466
   PubMed Web of Science ®Google Scholar
• Hwang, H. J., Park, S. Y., Lee, S. H., Han, S. B., & Ro, K. H. (2012, June). Differences in bone mineral density between the right and left hips in postmenopausal women. Journal of Korean Medical Science, 27(6), 686–690. https://doi.org/https://doi.org/10.3346/jkms.2012.27.6.686
   PubMed Web of Science ®Google Scholar
• International Society for Clinical Densitometry. (2015). ISCD official position. Ref Type: Online Source https://www.iscd.org/official-positions/2015-iscd-official-positions-adult_10-12-2018
   Google Scholar
• Kooij, K. W., Wit, F. W., Bisschop, P. H., Schouten, J., Stolte, I. G., Prins, M., van der Valk, M., Prins, J. M., van Eck-smit, B. L. F., Lips, P., & Reiss, P. (2015, February 15). Low bone mineral density in patients with well-suppressed HIV infection: Association with body weight, smoking, and prior advanced HIV disease. The Journal of Infectious Diseases, 211(4), 539–548.
   PubMed Web of Science ®Google Scholar
• Liu, A. Y., Vittinghoff, E., Sellmeyer, D. E., Irvin, R., Mulligan, K., Mayer, K., Thompson, M., Grant, R., Pathak, S., O’Hara, B., Gvetadze, R., Chillag, K., Grohskopf, L., & Buchbinder, S. P. (2011). Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One, 6(8), e23688. https://doi.org/https://doi.org/10.1371/journal.pone.0023688
   PubMed Web of Science ®Google Scholar
• Lohse, N., & Obel, N. (2016, November). Update of survival for persons with HIV infection in Denmark. Annals of Internal Medicine, 165(10), 749–750. https://doi.org/https://doi.org/10.7326/L16-0091
   PubMed Web of Science ®Google Scholar
• Martin, A., Bloch, M., Amin, J., Baker, D., Cooper, D. A., Emery, S., Bedimo, R. J., Drechsler, H., Jain, M., Cutrell, J., Zhang, S., Li, X., Farukhi, I., Castanon, R., Tebas, P., & Maalouf, N. M. (2009, November). Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: A randomized, 96-week trial. Clinical Infectious Diseases, 49(10), 1591–1601. https://doi.org/https://doi.org/10.1086/644769
   PubMed Web of Science ®Google Scholar
• McComsey, G. A., Lupo, S., Parks, D., Poggio, M. C., De, W. J., Kahl, L. P., Angelis, K., Wynne, B., Vandermeulen, K., Gartland, M., Cupo, M., & Aboud, M. (2018, February). Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health. AIDS, 32(4), 477–485. https://doi.org/https://doi.org/10.1097/QAD.0000000000001725
   PubMed Web of Science ®Google Scholar
• Multanen, J., Nieminen, M. T., Hakkinen, A., Kujala, U. M., Jamsa, T., Kautiainen, H., Lammentausta, E., Ahola, R., Selänne, H., Ojala, R., Kiviranta, I., & Heinonen, A. (2014, January). Effects of high-impact training on bone and articular cartilage: 12-month randomized controlled quantitative MRI study. Journal of Bone and Mineral Research, 29(1), 192–201. https://doi.org/https://doi.org/10.1002/jbmr.2015
   PubMed Web of Science ®Google Scholar
• Ofotokun, I., Titanji, K., Lahiri, C. D., Vunnava, A., Foster, A., Sanford, S. E., Sheth, A. N., Lennox, J. L., Knezevic, A., Ward, L., Easley, K. A., Powers, P., & Weitzmann, M. N. (2016, September). A single-dose zoledronic acid infusion prevents antiretroviral therapy-induced bone loss in treatment-naive HIV-infected patients: A phase IIb trial. Clinical Infectious Diseases, 63(5), 663–671. https://doi.org/https://doi.org/10.1093/cid/ciw331
   PubMed Web of Science ®Google Scholar
• Ofotokun, I., & Weitzmann, M. N. (2011, May). HIV and bone metabolism. Discovery Medicine, 11(60), 385–393.
   PubMed Web of Science ®Google Scholar
• Omland, L. H., Ahlstrom, M. G., & Obel, N. (2014, December). Cohort profile update: The Danish HIV Cohort Study (DHCS). International Journal of Epidemiology, 43(6), 1769–9e. [pii];https://doi.org/10.1093/ije/dyu153
   PubMed Web of Science ®Google Scholar
• Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998, March 26). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853–860. https://doi.org/https://doi.org/10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Rasmussen, L. D., May, M. T., Kronborg, G., Larsen, C. S., Pedersen, C., Gerstoft, J., & Obel, N. (2015, July). Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: A nationwide population-based cohort study. The Lancet HIV, 2(7), e288–e298. https://doi.org/https://doi.org/10.1016/S2352-3018(15)00077-6
   PubMed Web of Science ®Google Scholar
• Ripa, M., Chiappetta, S., & Tambussi, G. (2017, July). Immunosenescence and hurdles in the clinical management of older HIV-patients. Virulence, 8(5), 508–528. https://doi.org/https://doi.org/10.1080/21505594.2017.1292197
   PubMed Web of Science ®Google Scholar
• Shaiykova, A., Pasquet, A., Goujard, C., Lion, G., Durand, E., Bayan, T., Lachâtre, M., Choisy, P., Ajana, F., Bourdic, K., Viget, N., Riff, B., Quertainmont, Y., Cortet, B., Boufassa, F., & Chéret, A. (2018, November). Reduced bone mineral density among HIV-infected, virologically controlled young men: Prevalence and associated factors. AIDS, 32(18), 2689–2696. https://doi.org/https://doi.org/10.1097/QAD.0000000000002001
   PubMed Web of Science ®Google Scholar
• Shiels, M. S., & Engels, E. A. (2017, January). Evolving epidemiology of HIV-associated malignancies. Current Opinion in HIV and AIDS, 12(1), 6–11. https://doi.org/https://doi.org/10.1097/COH.0000000000000327
   PubMed Web of Science ®Google Scholar
• Starup-Linde, J., Rosendahl, S. B., Storgaard, M., & Langdahl, B. (2020, January). Management of osteoporosis in patients living with HIV-A systematic review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 83(1), 1–8. https://doi.org/https://doi.org/10.1097/QAI.0000000000002207
   PubMed Web of Science ®Google Scholar
• Teeraananchai, S., Kerr, S. J., Amin, J., Ruxrungtham, K., & Law, M. G. (2017, April). Life expectancy of HIV-positive people after starting combination antiretroviral therapy: A meta-analysis. HIV Medicine, 18(4), 256–266. https://doi.org/https://doi.org/10.1111/hiv.12421
   PubMed Web of Science ®Google Scholar
• Thorsteinsson, K., Ladelund, S., Jensen-Fangel, S., Larsen, M. V., Johansen, I. S., Katzenstein, T. L., Pedersen, G., Storgaard, M., Obel, N., & Am, L. (2012, October). Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: A nationwide cohort study. Scandinavian Journal of Infectious Diseases, 44(10), 766–775. https://doi.org/https://doi.org/10.3109/00365548.2012.684220
   PubMed Web of Science ®Google Scholar
• Tinago, W., Cotter, A. G., Sabin, C. A., Macken, A., Kavanagh, E., Brady, J. J., McCarthy, G., Compston, J., & Mallon, P. W. G. (2017, March). Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients. AIDS, 31(5), 643–652. https://doi.org/https://doi.org/10.1097/QAD.0000000000001372
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008, September). Fracture prevalence among Human Immunodeficiency Virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. The Journal of Clinical Endocrinology & Metabolism, 93(9), 3499–3504. https://doi.org/https://doi.org/10.1210/jc.2008-0828
   PubMed Web of Science ®Google Scholar
• van Sighem, A. I., Gras, L. A., Reiss, P., Brinkman, K., & De, W. F. (2010, June 19). Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS, 24(10), 1527–1535. https://doi.org/https://doi.org/10.1097/QAD.0b013e32833a3946
   PubMed Web of Science ®Google Scholar
• Wessman, M., Thorsteinsson, K., Storgaard, M., Ronsholt, F. F., Johansen, I. S., Pedersen, G., Nielsen, L. N., Wies, N., Katzenstein, T. L., & Lebech, A.-M. (2017, July). HIV disclosure and stigma among women living with HIV in Denmark. Journal of Virus Eradication, 3(3), 140–144. https://doi.org/https://doi.org/10.1016/S2055-6640(20)30332-0
   PubMed Web of Science ®Google Scholar
• Womack, J. A., Goulet, J. L., Gibert, C., Brandt, C., Chang, C. C., Gulanski, B., Fraenkel, L., Mattocks, K., Rimland, D., Rodriguez-Barradas, M. C., Tate, J., Yin, M. T., & Justice, A. C. (2011, February). Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One, 6(2), e17217. https://doi.org/https://doi.org/10.1371/journal.pone.0017217
   PubMed Web of Science ®Google Scholar
• Zengin, A., Prentice, A., & Ward, K. A. (2015). Ethnic differences in bone health. Frontiers in Endocrinology, 17(6), 24. https://doi.org/https://doi.org/10.3389/fendo.2015.00024
   Google Scholar